These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 8318868
1. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide. Larsen M. Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868 [Abstract] [Full Text] [Related]
2. Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide. Larsen M, Dalgaard P, Lund-Andersen H. Graefes Arch Clin Exp Ophthalmol; 1991; 229(4):350-7. PubMed ID: 1916323 [Abstract] [Full Text] [Related]
3. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Sander B, Larsen M, Moldow B, Lund-Andersen H. Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879 [Abstract] [Full Text] [Related]
4. Vitreous fluorophotometric evaluation of diabetics. Bursell SE, Delori FC, Yoshida A, Parker JS, Collas GD, McMeel JW. Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):703-10. PubMed ID: 6724841 [Abstract] [Full Text] [Related]
5. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Moldow B, Sander B, Larsen M, Lund-Andersen H. Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1770-5. PubMed ID: 10393047 [Abstract] [Full Text] [Related]
6. Vitreous fluorophotometry in juvenile diabetes. Kernell A, Larsson Y, Ludvigsson J, Tenland T. Acta Endocrinol Suppl (Copenh); 1980 Jul; 238():67-74. PubMed ID: 6933816 [Abstract] [Full Text] [Related]
9. [Microscopic quantification of fluorescein distribution in retinas of normal and diabetic rats]. Proença D, Proença RD, Cunha-Vaz JG. J Fr Ophtalmol; 1990 Jul; 13(10):489-91. PubMed ID: 2081838 [Abstract] [Full Text] [Related]
10. [Structural and functional disorders of transcapillary metabolism if retina in patients with diabetic retinopathy]. Sorokin EL, Smoliakova GP. Vestn Oftalmol; 1997 Jul; 113(2):16-9. PubMed ID: 9229896 [Abstract] [Full Text] [Related]
11. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement. Prager TC, Chu HH, Garcia CA, Anderson RE, Field JB, Orzeck EA, Comstock JP. Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315 [Abstract] [Full Text] [Related]
12. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study. Gardner TW, Eller AW, Friberg TR, D'Antonio JA, Hollis TM. Retina; 1995 Jan; 15(2):134-40. PubMed ID: 7624601 [Abstract] [Full Text] [Related]
13. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes. Do carmo A, Ramos P, Reis A, Proença R, Cunha-vaz JG. Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219 [Abstract] [Full Text] [Related]
14. Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Lund-Andersen H, Krogsaa B, la Cour M, Larsen J. Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419 [Abstract] [Full Text] [Related]
16. Vitreous fluorophotometry: mathematical analysis of the effect of peripheral leakage on axial scans. Dalgaard P, Barker VA, Lund-Andersen H. Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1522-6. PubMed ID: 2744996 [Abstract] [Full Text] [Related]